PTX-912

· Proviva Therapeutics, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for PTX-912, covering 2024-11-07 to 2024-11-07. Get the full timeline:

Most recent: Clinical Trial Update: A First-in-human (FIH), Phase I Study of PTX-912 in Patients with Locally Advanced/Metastatic Solid Tumors [Phase 1]

See pricing